DIOS MEDICAL
ActiveSummary
DIOS MEDICAL has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5k and a net result of €150k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 9% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
69
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency29▼-71
Growth32▼-46
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
4.2%
Return on assets
120.1%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 9%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
126 d early
2024
59 d early
2023
55 d early
2022
47 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€5k▼ 99.1%
2024 · €605k
2022: €173k
2023: €361k
2024: €605k
2022 → 2025
Total assets
€125k▼ 80.6%
2024 · €645k
2022: €223k
2023: €433k
2024: €645k
2022 → 2025
Net result
€150k▼ 38.3%
2024 · €243k
2022: €173k
2023: €189k
2024: €243k
2022 → 2025
Working capital
€960▼ 99.8%
2024 · €596k
2022: €173k
2023: €346k
2024: €596k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€173k-€361k▲ 109%€605k▲ 67.4%€5k▼ 99.1%
Operating result€224k-€246k▲ 9.8%€312k▲ 26.9%€196k▼ 37.3%
Net result€173k-€189k▲ 9.1%€243k▲ 28.9%€150k▼ 38.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 37% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €125k
Fixed assets
€4k ▼ 51.2%
Current assets
€121k ▼ 81.0%
Equity and liabilities €125k
Equity
€5k ▼ 99.1%
Debt
€120k ▲ 202%
Debt's share of the balance-sheet total rises from 6.2% to 95.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€203k▼
2024 · €319k
Cash flow
€157k▼
2024 · €250k
Current ratio
1.01▼
2024 · 16.03
Debt to equity
23.04▲
2024 · 0.07
ROA
120.1%▲
2024 · 37.8%
Interest coverage
1896.65▲
2024 · 1824.03
Debt ≤ 1 year
€120k▲
2024 · €40k
Income taxes
€45k▼
2024 · €76k
A ratio outside any meaningful range has been withheld (balance sheet total €125k, equity €5k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet
Code20242025
Assets
Total assets20/58€645k€125k▼
Fixed assets21/28€9k€4k▼
Tangible fixed assets22/27€9k€4k▼
Furniture and vehicles24€9k€2k▼
Other tangible fixed assets26-€2k
Current assets29/58€636k€121k▼
Amounts receivable within one year40/41€293k€49k▼
Trade receivables40€58k€49k▼
Other amounts receivable41€234k€0▼
Cash at bank and in hand54/58€343k€72k▼
Deferred charges and accrued income490/1€228€0▼
Equity and liabilities
Total equity and liabilities10/49€645k€125k▼
Equity10/15€605k€5k▼
Contributions10/11€1k€1k=
Profit (loss) carried forward14€604k€4k▼
Amounts payable17/49€40k€120k▲
Amounts payable within one year42/48€40k€120k▲
Trade debts44€30€148▲
Suppliers440/4€30€148▲
Taxes, remuneration and social security45€40k€32k▼
Taxes450/3€40k€32k▼
Remuneration and social security454/9€0-
Other amounts payable47/48€0€88k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€7k▲
Other operating charges640/8€851€530▼
Gross operating margin9900€320k€203k▼
Operating profit (loss)9901€312k€196k▼
Financial income75/76B€7k€0▼
Recurring financial income75€7k€0▼
Financial charges65/66B€175€107▼
Recurring financial charges65€175€107▼
Profit (loss) for the period before taxes9903€319k€196k▼
Income taxes67/77€76k€45k▼
Profit (loss) for the period9904€243k€150k▼
Profit (loss) for the period to be appropriated9905€243k€150k▼
Appropriation of the result
Profit (loss) to be appropriated9906€604k€754k▲
Profit (loss) brought forward from the previous period14P€360k€604k▲
Profit to be distributed694/7€0€750k▲
Return on contributions (dividend)694€0€750k▲
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €150k ▼38.3%
Net result drops to €150k, the lowest in the series.
02-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €243k ▲28.9%
Operating result €312k, net result €243k, both a record.
31-12
Financial
Liquidity triplescurrent ratio 16.03
Current ratio from 5.80 to 16.03; short-term debt falls from €72k to €40k.
31-12
Financial
Equity above €500kEq €605k ▲67.4%
3 profitable years in a row build equity to €605k.
06-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €200kEq €361k ▲109%
2 profitable years in a row build equity to €361k.
14-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Terkamerenboslaan 611050 ElseneGround area
209 m²
Building footprint
71 m²
Volume, LiDAR
937 m³
Parcel 21446D0059/00M003, Brussels · tallest building 17.2 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
DIOS MEDICAL
since 20222.337.457.401
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21446D0059/00M003 | Brussels | 208 m² | 1 · 71 m² | 17.2 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LABORIS MEDICA
BE 0781.879.287
Wemmel · Eq €5,208
CARDIO CITA
BE 1025.782.324
Modave · Eq €5,208
Dokter Julie Goderis
BE 0778.832.695
Nazareth-De Pinte · Eq €5,227
CABINET MEDICAL Virginie BALTHASAR
BE 0739.530.275
Aywaille · Eq €5,148
DR. VAN dE WALLE MIEKE, Oncoloog
BE 0758.798.732
Merelbeke-Melle · Eq €5,148
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 1,489 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded08-09-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.